AA
LLY icon

Argent Advisors’s Eli Lilly LLY Stock Holding History

Argent Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.01M Sell
4,357
-84
-2% -$85.2K 1.09% 23
2025
Q4 		$4.77M Buy
4,441
+187
+4% +$179K 1.33% 17
2025
Q3 		$3.25M Buy
4,254
+15
+0.4% +$11.2K 0.96% 28
2025
Q2 		$3.3M Sell
4,239
-6
-0.1% -$4.66K 1.02% 21
2025
Q1 		$3.51M Buy
4,245
+284
+7% +$236K 1.17% 19
2024
Q4 		$3.06M Sell
3,961
-80
-2% -$66.2K 1.13% 18
2024
Q3 		$3.58M Sell
4,041
-5
-0.1% -$4.5K 1.33% 17
2024
Q2 		$3.66M Sell
4,046
-10
-0.2% -$8K 1.46% 16
2024
Q1 		$3.16M Sell
4,056
-21
-0.5% -$14.9K 1.25% 18
2023
Q4 		$2.38M Sell
4,077
-10
-0.2% -$5.84K 1.04% 20
2023
Q3 		$2.2M Buy
4,087
+51
+1% +$26.3K 1% 22
2023
Q2 		$1.89M Sell
4,036
-75
-2% -$31.5K 0.87% 24
2023
Q1 		$1.41M Sell
4,111
-20
-0.5% -$6.75K 0.67% 39
2022
Q4 		$1.51M Sell
4,131
-400
-9% -$142K 0.78% 34
2022
Q3 		$1.47M Hold
4,531
– – 0.85% 27
2022
Q2 		$1.47M Hold
4,531
– – 0.83% 30
2022
Q1 		$1.3M Hold
4,531
– – 0.7% 47
2021
Q4 		$1.25M Hold
4,531
– – 0.67% 44
2021
Q3 		$1.05M Sell
4,531
-110
-2% -$27.1K 0.6% 52
2021
Q2 		$1.06M Sell
4,641
-195
-4% -$39.2K 0.65% 41
2021
Q1 		$903K Buy
4,836
+1,943
+67% +$380K 0.58% 45
2020
Q4 		$488K Sell
2,893
-1,471
-34% -$220K 0.3% 91
2020
Q3 		$646K Sell
4,364
-60
-1% -$9.29K 0.44% 66
2020
Q2 		$726K Sell
4,424
-147
-3% -$22.6K 0.56% 54
2020
Q1 		$634K Sell
4,571
-30
-0.7% -$4.12K 0.64% 45
2019
Q4 		$648K Buy
+4,601
New +$533K 0.48% 46

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Argent Advisors's LLY Position: Q1 2026 in Review

Argent Advisors reduced its Eli Lilly (LLY) stake by 1.9% in Q1 2026, selling an estimated $85.2K and leaving 4,357 shares worth $4.01M. The position accounts for 1.09% of the portfolio, ranked #23.

Argent Advisors first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.77M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Argent Advisors held 4,357 shares of Eli Lilly worth $4.01M as of Q1 2026.
  • Argent Advisors sold 84 Eli Lilly shares in Q1 2026, an estimated $85.2K.
  • Eli Lilly made up 1.09% of Argent Advisors's portfolio in Q1 2026, its #23 holding.
  • Argent Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • Argent Advisors's Eli Lilly position peaked at $4.77M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Argent Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.